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1. Introduction  
The cornea of the eye is avascular, clear, and 
transparent for light to pass into the retina. Under 
pathological conditions, such as trauma, 
inflammation, infection, and hypoxia, angiogenic 
factors, such as vascular endothelial growth factor 
(VEGF), bind to their receptor and result in an 
invasion of vessels from the limbal arcade to normally 
avascular cornea, leading to corneal 




Tacrolimus, an immunosuppressive agent, has been shown to be an effective 
treatment against corneal neovascularization (CNV). However, the poor solubility of 
this compound restricts its clinical application. The goal of this study was to 
incorporate tacrolimus into phospholipid-bile salt mixed micelles. 
Methods and Results:  
Tacrolimus loaded phospholipid-bile salt mixed micelles were prepared, employing 
three different methods of direct dispersion, thin film hydration, and remote film 
loading, and the effects of various formulation parameters (type of dispersion 
medium, phospholipid to bile salt molar ratio, lipid-to-drug (L/D) molar ratio, time of 
probe sonication, and type of bile salt) on the physicochemical characteristics of the 
mixed micelles were assessed. Remote film loading method indicated higher efficacy 
for drug entrapment in comparison to the other methods. Encapsulation of tacrolimus 
within the micelles increased remarkably by the use of sodium taurocholate (NaTC) 
as bile salt, higher phospholipid percentage, and increasing the total lipid level. 
Atomic force microscopy (AFM) studies confirmed the size and size distribution of 
the mixed micelles and their spherical morphology. It was observed that release of 
tacrolimus from the micelles was in a controlled manner, without an initial burst. 
Conclusion: 
By adjusting process and formulation factors, phospholipid-bile salt mixed micelles 
with high entrapment efficiency of (99.5%) and controlled release behavior were 
achieved, which possess great potential to be valuable carriers for ocular delivery of 
tacrolimus for the treatment of CNV. 
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cause of irreversible visual loss in a number of eye 
diseases, such as proliferative diabetic retinopathy, 
corneal graft rejection, age-related macular 
degeneration, retinopathy of prematurity, and 
traumatic corneal injury [2, 4]. Treatments for CNV, 
including topical corticosteroids, methotrexate, low-
molecular-weight heparin sulfate, topical 
bevacizumab, nonsteroidal anti-inflammatory agents, 
and laser photocoagulation have met limited success 
due to the poor understanding of CNV pathogenesis 
and low drug ocular bioavailability [5, 6]. 
Tacrolimus is a macrolide antibiotic that has been 
successfully used to prevent allograft rejection in 
kidney, liver, lung, and heart transplantation. 
Recently, systemic and topical tacrolimus 
administrations have been found to be efficacious for 
CNV inhibition [7, 8].  
However, drug bioavailability to the cornea is always 
challenging due to continuous clearance by the tear 
fluid. Furthermore, ocular barriers lead to poor drug 
permeation. Therefore, intravitreal injection and/or 
frequent use of eye drops throughout the day may be 
used, which are accompanied by various problems, 
such as cataract, endophthalmitis, vitreous 
hemorrhage, and blurred vision [9]. On the other hand, 
promising beneficial activity of tacrolimus has been 
limited mainly due to its poor water solubility. 
Nanoparticulate delivery systems have been 
successfully applied to improve ocular penetration, to 
sustain drug release, and to increase drug ocular 
residence time [10, 11]. 
Among various nanoparticles, micelles may be 
particularly useful for ocular delivery of poorly 
soluble drugs due to their unique combination of 
excellent properties, such as the solubilizing ability 
for lipophilic compounds, controlled release 
properties, fine particle size, biocompatibility, and 
enhanced permeability [12-14]. Mixed phospholipid-
bile salt nanomicelles have attracted great attention in 
recent years due to their solubilizing capacity and 
physiological biocompatibility [9, 15-17] and could 
also be good candidates for ocular delivery of 
tacrolimus. 
Therefore, the aim of the present study was to 
incorporate tacrolimus into phospholipid-bile salt 
mixed micelles. The effects of various parameters, 
such as preparation method, phospholipid percentage, 
lipid-to-drug (L/D) molar ratio, and type of bile salt 
on the physicochemical properties were then studied. 
2. Materials and Methods 
2.1. Materials 
Tacrolimus was kindly donated by Aburaihan 
Pharmaceutical Co. (Iran). Purified egg 
phosphatidylcholine (EPC) was purchased from 
Lipoid GmbH (Germany), and sodium cholate (NaC), 
sodium deoxycholate (NaDC), and sodium 
taurocholate (NaTC) were all obtained from Sigma-
Aldrich (Germany). Ethanol, HPLC-grade acetonitrile 
and methanol were supplied by Merck (Germany). 
Cellulose dialysis bag (molecular weight cutoff 
12,000 Da) was procured from Sigma-Aldrich 
(Germany). All other chemicals were of analytical 
grade or of the highest purity available. 
2.2. Micelle preparation 
To develop mixed micellar solutions, three methods of 
direct dispersion, thin film hydration, and remote film 
loading were investigated. 
2.2.1. Direct dispersion method 
For the preparation of micelles using direct dispersion 
method [18], EPC, NaC (40:60, molar ratio), and 
tacrolimus with a L/D molar ratio of 10:1, were 
dispersed together in phosphate buffer (PB; 0.067 M; 
pH 7.4) at 37 °C for 24 h by use of a thermostated 
magnetic stirrer. 
2.2.2. Thin film hydration method 
In thin film hydration method [19], EPC, NaC (40:60, 
molar ratio), and drug with a L/D molar ratio of 10:1 
were dissolved in methanol in a round-bottomed flask. 
The solution was subsequently evaporated under 
reduced pressure using a rotary evaporator (Heidolph, 
Germany) at 65 °C for 30 min to yield a thin film on 
the wall of the flask. Evaporation was continued for at 
least 2 h after the dry residue appeared, to remove all 
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traces of the organic solvent. Micelles were prepared 
by a vigorous vortexing of the film with PB (0.067 M; 
pH 7.4), which was followed by sonication 
(Powersonic 405, Hwashin Technology Co., Korea) at 
30 °C for 10 min. 
2.2.3. Remote film loading method 
Remote film loading method involves the 
development of drug film and its subsequent addition 
to empty micelles.  
In order to prepare empty micelles, a mixture of EPC 
and bile salt (NaC, NaDC, or NaTC) 
in desired molar ratio was dispersed in an aqueous 
medium at 60 °C for 1 h and then at 37 °C for 47 h by 
use of a thermostated magnetic stirrer. 
After that, methanolic solutions of tacrolimus were 
prepared and then evaporated under reduced pressure 
using the rotary evaporator to develop a thin-layer 
film. To prepare loaded micelles, the empty micelles 
were added to the dried drug film and the mixture was 
then sonicated for 30 min at 30 °C [20]. 
2.3. Micelle characterization 
The prepared micelles were characterized in terms of 
particle size and size distribution, zeta potential, 
morphology, entrapment efficiency, in-vitro release 
profile, and stability. 
2.3.1. Size distribution and zeta potential   
Size, population distribution, and zeta potential of the 
micelles were determined by dynamic light scattering 
measurements carried out on a Malvern Zetasizer 
Nano (Malvern Instruments Ltd, UK). The analysis 
was conducted at 25 °C after the samples had been 
diluted with deionized water. The measurements were 
performed in triplicate and the results were presented 
as the mean ± standard deviation (SD). 
2.3.2. Morphology  
The morphology of the micelles was visualized via 
atomic force microscopy (AFM). For this purpose, the 
micelles were diluted with deionized water and an 
aliquot (20 μL) of the diluted micelles was 
immediately mounted onto the freshly cleaved mica 
surface, spread thin, and then dried at ambient 
temperature (25 °C). Contact mode was carried out, 
employing a Nanowizard II atomic force microscope 
(JPK Instruments, Germany) through the use of low-
stress silicon nitride cantilevers (AppNano, USA).  
2.3.3. Entrapment efficiency  
To determine tacrolimus content in the micelles, the 
non-incorporated drug was separated from the drug 
encapsulated in micelles using centrifugation at 
14,000 rpm for 15 min. Afterwards, small aliquots of 
the micelles (50 μL) were lysed with methanol (950 
μL), bath-sonicated until micelles disruption, and then 
analyzed for tacrolimus content by HPLC. The 
percent of entrapment efficiency (% EE) was 
calculated from the amount of entrapped tacrolimus 
divided by the total amount of drug used initially for 
preparation multiplied by 100. 
2.3.4. In-vitro drug release 
The in-vitro release of tacrolimus from the micelles 
was studied through cellulose dialysis bag. 
Tacrolimus-loaded micelles (0.5 mL) were transferred 
into the bag and dialyzed against releasing medium 
(PB (0.067 M; pH 7.4) containing 30% ethanol for 
achieving sink condition) under 100 rpm magnetic 
stirring, at 37 °C. At predetermined intervals (1, 2, 3, 
4, 6, and 8 h), 1 mL aliquots of the release media were 
withdrawn and replenished with the same volume of 
fresh media to maintain sink condition. Each 
experiment was performed in triplicate and the 
collected samples were analyzed by HPLC.  
2.3.5. Drug analysis 
The amount of tacrolimus in micelles and in release 
medium was quantified through a validated HPLC 
method. The HPLC system (Knauer, Germany) 
employed composed of a WellChrom K-1001 solvent 
delivery pump with an online degasser, a column 
oven, and a K-2600 ultraviolet (UV) detector. 
Chromgate software (Version 317) was used to record 
and process the data obtained during chromatographic 
analysis. The separation was carried out through a 
PerfectSil ® C18 column, 150×4.6 mm, 3.5 μm 
particle size (MZ-Analysentechnik GmbH, Germany), 
with a mobile phase of water and acetonitrile (20:80, 
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v/v) at a flow rate of 1 mL/min. The eluent was 
monitored via UV detection at a wavelength of 
210 nm. The injection volume was 100 μL and the 
column was maintained at 45 °C. Prior to the analysis, 
method validation was conducted in accordance with 
the International Conference on Harmonization (ICH) 
guidelines in terms of selectivity, accuracy, precision, 
linearity, limit of detection (LOD), and limit of 
quantification (LOQ) [21]. 
2.3.6. Stability study 
The stability of the micelles was assessed at 4 °C for a 
period of 1 month. At specified time intervals, 
aliquots of samples were taken out, and the 
characteristics of EE (%), particle size, and its 
distribution were investigated. 
2.4. Statistical analysis 
All statistical analyses were conducted using SPSS 
version 17 (SPSS Inc., USA). The data were presented 
as the mean ± SD. The comparison of the 
formulations was performed through analysis of 
variance; p-value < 0.05 was considered to indicate 
statistical significance. 
3. Results 
3.1. Preparation of micelles 
Micelles can be developed using numerous 
preparation methods. The choice of an appropriate 
method depends on the physicochemical 
characteristics of each cargo. For this purpose, 
preliminary studies were performed, utilizing three 
methods of direct dispersion, thin film hydration, and 
remote film loading. A series of formulations were 
developed by the first two methods, altering type of 
dispersion medium (distilled water, normal saline 
(NaCl 0.9% w/v), phosphate buffered saline (PBS; pH 
7.4), and PB (0.067 M, pH 7.4)) and time of 
hydration, while, keeping other parameters invariant. 
As shown in Table 1, both methods were not very 
effective, having large particle sizes, with average 
diameters in the range of about 150 to 300 nm, and 
broad size distribution. Remote film loading method 
clearly gave micelles with smaller particle sizes. In the 
next step, to optimize the size of the micelles prepared 
by remote film loading method, two methods of high 
frequency probe sonication at an amplitude of 150 W 
and bath sonication after hydration were investigated. 
Bath sonication after hydration gave significantly 
smaller size (93.4 ± 16.3 nm); however, with a highly 
disperse size 
distribution (PDI = 0.96 ± 5.06), which is considered 
not to be suitable for ocular delivery. Using probe 
sonication after hydration yielded micelles with a 
particle size of 88.3 ± 10.6 nm, narrower size 
distribution (PDI = 0.15 ± 0.00), and higher EE (%). 
Thus, remote film loading followed by probe 
sonication after hydration was utilized for tacrolimus 
micelle preparation.  
Table 1 Effect of preparation method on particle size 
and % EE of tacrolimus-loaded micelles;  
data are represented as mean ± SD (n = 3). 
Formulation Preparation 
method 
Size (nm ) EE (%) 
F1 Direct 
dispersion 
179.9 ± 6.1 10.3 ± 3.0 
F2 Thin film 
hydration 
301.3 ± 6.6 32.7 ± 4.3 
F3 Remote film 
loading 
93.4 ± 16.3 43.0 ± 6.6 
 
3.2. Factors affecting physicochemical properties of 
micelles 
To identify a micellar formulation with appropriate 
physicochemical properties, various factors were 
assessed and optimized, including the type of 
dispersion medium, EPC to bile salt molar ratio, L/D 
molar ratio, time of probe sonication, and type of bile 
salt surfactant.  
3.2.1. Type of dispersion medium 
For studying the effect of dispersion medium, four 
different mediums of distilled water, normal saline 
(NaCl 0.9% w/v), PBS (pH 7.4), and PB (0.067 M, pH 
7.4) were investigated for the preparation of NaC-
containing micelles with fixed molar ratios of 
EPC/NaC (40:60) and L/D (10:1) (Table 2, 
formulations F4 to F7). As presented in Table 2, of the 
different types of medium employed, the distilled 
water and normal saline resulted in micelles with 
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broad size distributions (PDI > 0.3), while, using PBS 
(pH 7.4) and PB (0.067 M, pH 7.4) both yielded 
micelles with significantly narrower size distributions 
(PDI ~ 0.1). However, PB caused a substantial and 
significant increase of EE (%), so it was selected as 
the best dispersion medium and used in formulations 
F7 to F23 to evaluate other formulation parameters.  
 
Table 2 Effect of bile salt type, bile salt to phosphatidylcholine molar ratio, L/D ratio, medium type, and 
sonication time on particle size, size distribution, and % EE of tacrolimus-loaded NaC-containing micelles 
prepared using remote film loading method; data are represented as mean ± SD (n = 3). 







time (min)  
Size   
(nm) 
PDI EE  
(%) Bile salt 
surfactant 
Phosphatidylcholine 
F4 60 40 10 Distilled 
water 





F5 60 40 10 Normal 
saline 

















F8 70 30 10 PB 10 - - 51.7 ± 
1.5 
F9 30 70 10 PB 10 - - 64.6 ± 
3.5 
F10 30 70 20 PB 10 - - 72.0 ± 
3.2 






3.2.2. EPC to bile salt molar ratio 
Regarding the results, the EPC to bile salt molar ratio 
was found to have a considerable effect on the drug 
entrapment efficiency. Altering the EPC to bile salt 
molar ratio from (30:70) to (70:30), while keeping 
other parameters invariant, improved the EE (%) from 
51.7 ± 1.5 to 64.6 ± 3.5 for NaC- (Table 2), from 53.3 
± 0.8 to 60.6 ± 1.1 for NaDC- (Table 3), and from 
55.3 ± 1.7 to 63.4 ± 0.6 for NaTC- (Table 4) 
containing micelles, which all were statistically 
significant (P ˂ 0.001).  
 
Table 3 Effect of bile salt surfactant type, bile salt surfactant to phosphatidylcholine molar ratio, L/D ratio, 
medium type, and sonication time on particle size, size distribution, and % EE of tacrolimus-loaded NaDC-
containing micelles prepared using remote film loading method; data are represented as mean ± SD (n = 3). 







time (min)  
Size   
(nm) 
PDI EE  
(%) Bile salt 
surfactant 
Phosphatidylcholine 
F12 70 30 10 PB 10 - - 53.3 ± 
0.8 
F13 30 70 10 PB 10 - - 60.6 ± 
1.1 
F14 30 70 20 PB 10 - - 76.9 ± 
1.6 
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3.2.3. L/D molar ratio 
By keeping a constant EPC to bile salt molar ratio 
(70:30), the micelles with two L/D molar ratios (10:1 
and 20:1) were prepared using all three different bile 
salts and investigated for tacrolimus entrapment. The 
results indicate that the increase of L/D molar ratio, 
from (10:1) to (20:1), gave rise to about 7.4 (Table 2), 
16.3 (Table 3), and 22.0% (Table 4) enhancement of 
tacrolimus entrapment for micelles composed of NaC 
(P ˂ 0.05), NaDC (P ˂ 0. 01), and NaTC (P ˂ 0.001), 
respectively. 
 
Table 4 Effect of bile salt surfactant type, bile salt surfactant to phosphatidylcholine molar ratio, L/D ratio, medium 
type, and sonication time on particle size, size distribution, and % EE of tacrolimus-loaded NaTC-containing micelles 
prepared using remote film loading method; data are represented as mean ± SD (n = 3). 







time (min)  
Size   
(nm) 
PDI EE  
(%) Bile salt 
surfactant 
Phosphatidylcholine 
F16 70 30 10 PB 10 - - 55.3 ± 1.7 
F17 70 30 10 PB 20 - - 21.8 ± 2.7 
F18 30 70 10 PB 10 - - 63.4 ± 0.6 
F19 30 70 10 PB 20 - - 39.3 ± 1.6 
F20 70 30 20 PB 10 - - 19.7 ± 0.6 
F21 70 30 20 PB 20 - - 31.8 ± 0.8 
F22 30 70 20 PB 10 - - 85.4 ± 1.8 





99.5 ± 2.2 
3.2.4. Time of sonication 
For investigating the effect of sonication time on EE 
(%), NaTC-micelles with two levels for molar ratios 
of EPC to bile salt (30:70 and 70:30) and L/D (10:1 
and 20:1) were prepared at two sonication times of 10 
and 20 min. Regarding the results from Table 4, 
increasing the time of sonication from 10 to 20 min at 
L/D molar ratio of (10:1) led to reduction of EE (%) 
for micelles with both, low, and high EPC to bile salt 
molar ratios, whereas, at L/D molar ratio of (20:1) 
their EE (%) increased with increasing of time. 
3.2.5. Type of bile salt 
Bile salts, one of the major components of mixed 
micelle, can play a key role in the micelle properties. 
Thus, to assess the effects of bile salt structure on EE 
(%), a number of micellar formulations, containing 
NaC, NaDC, or NaTC with fixed molar ratios of EPC 
to bile salt (70:30) and L/D (20:1) were prepared by 
20 min sonication. The results revealed that of the 
different types of bile salt used, NaTC yielded 
micelles with considerably narrower size distribution 
(PDI = 0.02 ± 0.03), and higher tacrolimus entrapment 
(99.5 ± 2.2%) (Table 4, F23). 
3.3. Morphology 
The surface morphology of the optimized micelles, 
consisting of NaTC and EPC (30:70) with L/D molar 
ratio of (20:1) prepared by remote film loading 
method followed by probe sonication for 20 min was 
represented in Figure. 1. The prepared micelles were 
uniform in size with an average particle size of about 
90 nm and spherical in shape. 
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Figure. 1. AFM micrographs of the optimized 
formulation. 
 
3.4. In-vitro drug release 
The release profile of tacrolimus from the optimized 
micelles in PB (0.067 M; pH 7.4) containing 30% 
ethanol is depicted in Figure. 2. No significant burst 
effect was observed on the profile of the formulation, 
and it showed that 74.1 ± 8.6% of the drug was 
released within 8 h, indicating the usefulness of the 
proposed micellar delivery system for ocular delivery 
of tacrolimus. 
 
Figure. 2. In-vitro release profile of tacrolimus from the optimized formulation; data are represented as 
mean ± SD (n = 3). 
 
3.5. Stability study 
The physicochemical stability of the optimized 
micelles was investigated at 4 °C for a period of 1 
month. The results of the stability study are 
summarized in Table 5, showing that the micelles did 
not suffer a significant change in their size 
characteristics; however, it should be noted that their 
entrapment efficiency decreased by about 24%. 
 
Table 5 Stability of the optimized formulation stored at 
4 °C for 1 month; data are represented as mean ± SD 
(n = 3). 
Duration 
(day) 
Size (nm ) PDI Zeta-
potential 
EE (%) 
0 84.1 ± 1.6 0.02 ± 
0.03 
-32.7 99.5 ± 2.2 
7 84.9 ± 0.0 0.04 ± 
0.00 
-33.4 98.0 ± 0.1 
14 86.6 ± 0.9 0.01 ± 
0.00 
-35.9 87.9 ± 3.9 
21 86.3 ± 1.7 0.03 ± 
0.01 
-31.0 87.7 ± 3.1 
30 86.4 ± 1.2 0.02 ± 
0.10 
-31.2 75.7 ± 3.9 
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4. Discussion and Conclusion 
Mixed micelles have represented a milestone in the 
field of novel drug delivery with a considerable 
potential for encapsulation of poorly water-soluble 
drugs [18, 22, 23]. Their attraction lies in their 
composition, consisting of water-insoluble 
phospholipid molecules, located adjacent to a 
surfactant, which develop a structure with a 
hydrophobic core as a reservoir of hydrophobic 
compounds, and hydrophilic corona to provide 
stabilization against the external medium. Their 
unique characteristics, including nano-scale particle 
size, high thermodynamic stability, biocompatibility, 
cost-effectiveness, and ease of large-scale production 
make them interesting candidates for a variety of 
applications [18, 24]. Considering all these desirable 
features, we aimed to develop and optimize the mixed 
micelles, being composed of a phospholipid (EPC) 
and a bile salt (NaC, NaDC, or NaTC), for ocular 
delivery of tacrolimus to use against CNV.  
Since particle size exerts a significant effect on the 
performance of colloidal drug delivery systems, we 
first investigated the effect of preparation method on 
the particle size and its distribution. As represented in 
Table 1, the mixed micelles prepared by direct 
dispersion and thin film hydration methods were 
larger than 100 nm in size and indicated wide size 
distribution. While, the particle size and its 
distribution were dramatically decreased by remote 
film loading method, and the lowest diameter (88 nm) 
of micelles could be achieved when their preparation 
was followed by probe sonication. Owing to the 
presence of the water-insoluble phospholipids, the 
mixed micelles have been found to show a 
hydrodynamic diameter that can be larger than those 
for typical micelles [25-28]. In the absence of 
additional high energy input, such as probe sonication, 
large dispersed particles will be expected, which can 
be explained by inefficient solubilization of 
phospholipid molecules by surfactant molecules (bile 
salt), leading to an oversaturation of the system with 
respect to phospholipid and the subsequent formation 
of phospholipid aggregates dispersed into the 
saturated system. 
In order to achieve an optimal formulation capable of 
being used in the ocular delivery of tacrolimus, 
different mixed micellar formulations were prepared 
and the effects of various factors, including type of 
dispersion medium, EPC to bile salt molar ratio, L/D 
molar ratio, time of probe sonication, and type of bile 
salt surfactant on the physicochemical characteristics 
of the micelles were extensively evaluated.  
As shown in Tables 2-4, a significant increase in 
tacrolimus entrapment of the mixed micelles 
prepared using all three different bile salts was 
found with the increase in the ratio of EPC to bile 
salt. This enhancement may be explained by the fact 
that higher lipid content permits more hydrophobic 
interactions with lipophilic molecules of tacrolimus, 
leading to more incorporation of them into the 
micelles.  
The results revealed that another factor, having a 
considerable effect on tacrolimus entrapment, is the 
L/D molar ratio. Increasing of this ratio augmented the 
% EE for micelles containing each of the three bile 
salts (Tables 2-4). It is clear that increasing the 
concentration of micelle membrane-forming materials, 
which increases the number of nanocarriers per unit 
volume, can lead to an increase in the amount of drug 
incorporated in the carriers [19, 29]. Although 
enhancement of this ratio results in higher EE (%), in 
some cases, it can cause increase the viscosity of the 
system, which is not desirable. An additional increase 
of this ratio was not studied since high amounts of 
lipid and surfactant may worsen the physical 
characteristics of the formulation, raise toxicity 
concerns, and negatively influence the economic 
feasibility of pharmaceutical scale production. 
The structure of bile salt can be another factor, 
affecting the physicochemical characteristics of the 
mixed micelles. Thus, in this study, three types of bile 
salts were employed to prepare mixed micellar 
systems. The molar ratios of EPC to bile salt and L/D 
were (70:30) and (20:1), respectively, and kept 
constant in all three systems. As can be seen (Tables 
2-4), among all three bile salts, NaTC combining with 
PC achieved the highest entrapment of tacrolimus 
compared to NaC and NaDC. Higher EE (%) of NaTC 
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containing micelles may be interpreted by higher 
hydrophilic property of conjugated NaTC, leading to 
reduction of the mobility of water molecules adjacent 
to the surface of the micelles thanks to hydrogen 
bonding interactions, which can enhance the stability 
of the micelles and prevent drug molecules from 
moving out into the external medium. 
Regarding the obtained results, tacrolimus-loaded 
mixed micelles, consisting of EPC and NaTC (70:30) 
with L/D molar ratio of (20:1) prepared by remote 
film loading method (Table 4, F23), was found to be 
the optimized formulation, as it exhibited a narrow 
particle size range around 84.1 nm (PDI = 0.02 ± 
0.03) with the highest EE (99.5%). This formulation 
was thus chosen as the optimal mixed micelle and was 
used for further studies. 
In-vitro drug release studies indicated a controlled 
release of tacrolimus up to 74.1% for 8 h (Figure. 2), 
which is presumed to be ascribed to the high affinity 
of hydrophobic tacrolimus molecules for the 
hydrophobic materials in the system [30].  
Assessment of the mixed micelles stability in terms of 
their physicochemical characteristics unveiled that 
they were relatively unstable in the case of EE (%) 
(Table 5), which could be attributed to the detergent 
action of the bile salt, increasing the solubilization of 
the phospholipid constituent of the mixed micelles 
with the pass of time, and thus leading to leakage of 
the encapsulated molecules to some extent. 
According to these results, it can be deduced that the 
mixed micelle formulation proposed in this research 
may serve as a promising system for ocular delivery 
of tacrolimus. In order to confirm the efficacy and 
safety of this formulation, a series of in-vivo 
investigations, including pharmacokinetics, 
biodistribution, and inhibition effect on the CNV, and 
toxicity remain to be conducted in the future. 
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